1. Home
  2. FIHL vs AMPH Comparison

FIHL vs AMPH Comparison

Compare FIHL & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fidelis Insurance Holdings Limited

FIHL

Fidelis Insurance Holdings Limited

HOLD

Current Price

$19.71

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.37

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIHL
AMPH
Founded
2014
1996
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.2B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
FIHL
AMPH
Price
$19.71
$26.37
Analyst Decision
Hold
Buy
Analyst Count
7
6
Target Price
$21.14
$31.00
AVG Volume (30 Days)
637.7K
400.6K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
3.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$2,573,400,000.00
$723,305,000.00
Revenue This Year
$9.83
$1.35
Revenue Next Year
$9.44
$5.10
P/E Ratio
N/A
$12.04
Revenue Growth
11.89
N/A
52 Week Low
$14.17
$20.39
52 Week High
$19.76
$39.77

Technical Indicators

Market Signals
Indicator
FIHL
AMPH
Relative Strength Index (RSI) 64.30 50.72
Support Level $19.01 $25.16
Resistance Level $19.72 $27.44
Average True Range (ATR) 0.41 0.85
MACD 0.09 0.02
Stochastic Oscillator 96.55 45.54

Price Performance

Historical Comparison
FIHL
AMPH

About FIHL Fidelis Insurance Holdings Limited

Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: